Bleomycin Injection 15 Units Per Vial, Single-Dose Vial (Rx) *Refrigerated*

Bleomycin Injection by Himka Injectables is a potent antineoplastic agent used in the treatment of various cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and testicular cancer. Formulated for precision and efficacy, each single-dose vial contains 15 units of bleomycin, ensuring optimal therapeutic outcomes.

Product Details and Features

• Concentration: Each vial contains 15 units of bleomycin, designed for single-dose administration.
• Indications: Effective for treating Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, and certain types of squamous cell carcinoma.
• Quality Assurance: Produced following strict quality control standards to ensure safety and effectiveness.

Mechanism of Action

Bleomycin exerts its antitumor effects by binding to DNA, causing strand breaks and inhibiting DNA synthesis. This action leads to apoptosis of cancer cells, helping to reduce tumor size and progression.

Directions

1. Preparation: Reconstitute each vial with the appropriate diluent as specified by medical guidelines.
2. Administration: Administer intravenously, intramuscularly, or subcutaneously, based on clinical judgment and patient-specific factors.
3. Dosage: Follow the prescribed dosage regimen as directed by a healthcare professional experienced in cancer chemotherapy.
4. Monitoring: Regular monitoring of patient’s response and side effects is essential.

Warnings

• Administer only under the supervision of a qualified healthcare provider experienced in chemotherapy.
• Monitor pulmonary function regularly, as bleomycin may induce pulmonary toxicity.
• Avoid use in patients with pre-existing pulmonary conditions or compromised lung function.
• Potentially teratogenic; use effective contraception during treatment.
• Store vials at controlled room temperature and protect from light.

Side Effects

• Common: Fever, chills, nausea, vomiting, and injection site reactions.
• Serious: Pulmonary toxicity (e.g., pneumonitis, fibrosis), hypersensitivity reactions, and dermatological effects such as erythema and hyperpigmentation.
• Monitoring Required: Regular lung function tests and close observation for any adverse reactions.

Bleomycin Injection by Himka Injectables is a critical component in oncological therapy, delivering effective treatment while necessitating careful monitoring to ensure patient safety and optimal therapeutic results.